Home > Financial Ratios > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results

ALEMBIC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 11.629.2735.24-23.09-41.02

What is the latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS is 11.62 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202611.62
Mar20259.27
Mar202435.24
Mar2023-23.09
Mar2022-41.02

How is Core EBITDA Growth of ALEMBIC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 11.62
25.35
Mar2025 9.27
-73.69
Mar2024 35.24
Positive
Mar2023 -23.09
Negative
Mar2022 -41.02 -

Other Financial Ratios of ALEMBIC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹16,713.0 Cr 4.1% 15.1% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹116,164.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,648.0 Cr -3.2% -3.9% -3% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

4.1%

15.1%

-17.9%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses